Nanotechnology Now - Press Release: Solterra to Compete in $700 Million Quantum Dot Market: To Supply Cheaper, More Efficient Quantum Dots to Rapidly Growing Sector

Home > Press > Solterra to Compete in $700 Million Quantum Dot Market: To Supply Cheaper, More Efficient Quantum Dots to Rapidly Growing Sector

Abstract:
Hague Corp. ("Hague") (OTCBB: HGUE), a solar technology and quantum dot manufacturing company, today commented on recently released forecast for the Quantum Dot ("Solterra") market where it competes.

Solterra to Compete in $700 Million Quantum Dot Market: To Supply Cheaper, More Efficient Quantum Dots to Rapidly Growing Sector

Scottsdale, AZ | Posted on November 15th, 2008

A quantum dot is a semiconductor whose excitons are confined in all three spatial dimensions. As a result, they have properties that are between those of bulk semiconductors and those of discrete molecules.

Current and future applications of QDs impact a broad range of industrial markets. These include, for example, biology and biomedicine; computing and memory; electronics and displays; optoelectronic devices such as LEDs, lighting, and lasers; optical components used in telecommunications; and security applications such as covert identification tagging or biowarfare detection sensors.

According to a new report available at Electronics.ca Publications, the global market for QDs, which in 2008 is estimated to generate $28.6 million in revenues, is projected to grow over the next 5 years at a compound annual growth rate (CAGR) of 90.7%, reaching over $700 million by 2013. Following the initially modest revenues generated by standalone colloidal QDs - primarily serving the life sciences, academic, and other industrial research and development (R&D) communities - within the next 2 years several product launches with colloidal or in situ QD underpinning will bolster market revenue considerably.

"We are beginning to see comparisons to the early semiconductor industry in terms of growth prospect," said Stephen B. Squires, CEO and President of Solterra Renewable Technologies, Inc. Squires continued, "With the advances our scientists have made with this technology we are well positioned to dominate this industry over the next decade and take significant market share. While we are extremely encouraged by the latest market forecasts, we do believe this study underestimates the true size of the market."

Solterra has concluded the worldwide exclusive license with William Marsh Rice University for intellectual property which includes the "Synthesis of Uniform Nanoparticle Shapes with High Selectivity." The licensing agreement field of use covers the manufacture and sale of photovoltaic cells and the manufacture and sales of quantum dots for electronic and medical applications.

Rice University's breakthrough discovery has been the highlight of numerous scientific journal articles and also gained the attention of mainstream news media. This new chemical method for making low cost, four-legged cadmium selenide quantum dots, which previous research has shown to be particularly effective at converting sunlight into electrical energy, knocks down a major barrier in developing quantum-dot-based photovoltaics as an alternative to the conventional, more expensive silicon-based solar cells.

Solterra is scheduled to begin scale up of this technology in December 2008 with commercial production anticipated to begin in the second half of 2009.

####

About Hague Corp./Solterra Renewable Technologies, Inc.
Under their new business model Hague/Solterra is singularly positioned to lead the development of truly sustainable and cost-effective solar technology as the first company to introduce a new dimension of cost reduction by replacing silicon wafer-based solar cells with low-cost, highly efficient Quantum Dot-based solar cells.

Safe Harbor statement under the Private Securities Litigation Reform Act of 1995: The statements in this release relating to completion of the acquisition and the positive direction are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include, but are not limited to, contractual difficulties which may arise, the failure to obtain necessary approvals, the future market price of Hague Corp. common stock and/or the ability to obtain the necessary financing.

For more information, please click here

Contacts:
Hague Corp./Solterra Renewable Technologies, Inc.
Stephen B. Squires, President
Office: 954-384-1487

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark: